Abbott recognized as one of the `best places to work in iindustry` by the scientist magazine
Abbott has been named one of the Top 10 companies on The Scientist magazine's annual 'Best Places to Work in Industry' list. Abbott is the highest ranked health care company on the 2010 list, ranking No. 4 on the list of Large Companies. This is the seventh time that Abbott has been on the list since The Scientist first started ranking companies in 2003. This prestigious list is based on a detailed survey taken by scientists at life-science companies and research institutions worldwide. The rankings will be included in The Scientist's May issue, available in print and online today. 'Abbott's success begins with our scientists, and our inclusion on this list acknowledges our commitment to building a strong scientific community that is creative and collaborative in seeking new solutions for patients,' said John Leonard, M.D., senior vice president, Pharmaceuticals, Research and Development, Abbott. 'This year's winners include innovative companies that value scientific creativity and encourage employees to give back to their community,' said Edyta Zielinska, Associate Editor, The Scientist. Respondents to The Scientist survey were asked to assess their working environment according to 45 criteria in eight different categories, including overall job satisfaction, training, benefits and flexibility. Survey respondents cited training, educational development and a sense of community as top factors in establishing a positive workplace. At Abbott, employees are given opportunities to succeed, lead and grow in their careers through training, mentoring, networking groups and extensive development programs. Abbott scientists are rewarded through the Chairman's awards, President's awards, patent/inventor awards and induction into the prestigious Volwiler Society, which was established in 1985 to recognize the company's most distinguished scientists and engineers. Named for the late Ernest H. Volwiler, Ph.D., an internationally recognized scientist and former Abbott president and chairman of the board, the society encourages professional growth, and is meant to spur, recognize and showcase scientific innovation at Abbott. Each year, the Volwiler Society issues 'Outstanding Research' awards to the Abbott scientists and teams who have made significant contributions to their scientific fields. Abbott Widely Recognized as a Great Place to Work In addition to being recognized as a top employer for scientists, Abbott has been named a great place to work in more than 20 countries around the world. Abbott also has been named one of the '50 Best Places to Launch a Career' by BusinessWeek magazine, one of the Top 10 companies on Working Mother magazine's list of the '100 Best Companies,' and one of the top companies for diversity by DiversityInc magazine. Additionally, FORTUNE has named Abbott as one of 'America's Most Admired Companies' every year since the list's inception in 1983, including naming Abbott the No. 1 Most Admired Pharmaceutical Company in 2010. About The Scientist The Scientist, the award-winning magazine of the life sciences, has informed and entertained life science professionals around the world for more than 20 years. We provide print and online coverage of the latest developments in the life sciences including trends in research, new technology, news, business and careers. We reach the leading researchers in academia and industry who are interested in maintaining a broad view of the life sciences by reading insightful articles that are current, concise, accurate and entertaining. For more information about The Scientist, visit www.the-scientist.com. About Abbott Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs approximately 83,000 people and markets its products in more than 130 countries. Abbott's news releases and other information are available on the company's Web site at www.abbott.com.
Related news
-
Daxor Corporation to Commence Trading on the Nasdaq Capital Market
Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces that it will commence trading on The Nasdaq Capital Market effective at the opening of trading on February 2, 2022, transferring the listing of its common stock from the New York Stock Exchange – American. Daxor’s common stock will continue trading under the ticker symbol “DXR” after the transfer. The Company’s common stock will continue to trade on the NYSE American until the...
-
The Indoor Microbiome and Its Impact on Indoor Environmental Quality
Last year, the U.S. Environmental Protection Agency (EPA) announced the release of a new webpage to provide information about the indoor microbiome. All of the living microorganisms inside of an indoor environment, and their by-products, are collectively known as the indoor microbiome. The indoor microbiome that surrounds each of us is diverse and dynamic, made up of bacteria, viruses, fungi and other single-celled organisms. These microorganisms may be growing or inactive, and may be present in different life...
-
Daxor Corporation to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference
Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces that CEO and President Michael Feldschuh will present a corporate overview at the H.C. Wainwright BioConnect 2022 Virtual Conference, which is taking place on January 10 – 13, 2022. Mr. Feldshuh will provide company updates and key highlights, including a new patent award and progress with BVA-100® next generation development. The presentation will be available on-demand beginning at 7:00 a.m. ET...
-
Daxor Announces Key Milestones Achieved for Multicenter BVA-100 Study in Hospitalized Patients With COVID-19
Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, today announces patient enrollment is complete and data analysis is underway in preparation for publication of the multi-center observational prospective study utilizing Daxor’s BVA-100 (Blood Volume Analyzer, “BVA”) technology in hospitalized COVID-19 patients. NYU Langone Health, Wake Forest School of Medicine and OHSU have been enrolling subjects since the onset of the pandemic. Dr. Jan Bakker, MD,...
-
Daxor Awarded New Patent for Blood Volume Guidance Technology to Improve Treatment & Outcomes
Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, today announced that the United States Patent and Trademark Office has issued the company a new patent (U.S. Patent No. 11,204,356 B2) that protects a proprietary clinical guidance system for volume management utilizing unique volume metrics combined with treatment pathways. “We are very excited to receive this patent, which covers key innovations in the use of blood volume analysis to optimally guide fluid...
Customer comments
No comments were found for Abbott recognized as one of the `best places to work in iindustry` by the scientist magazine. Be the first to comment!